Daniel J. Schaid

Q: What Schools Are Affiliated With Daniel J. Schaid

Daniel J. Schaid is affiliated with the following schools: Medical College of Wisconsin, Saint Vincent College, University of Toronto, University of Pittsburgh

Daniel J. Schaid's AcademicInfluence.com Rankings

Daniel J. Schaid

Mathematics

#5253

World Rank

#7408

Historical Rank

#1747

USA Rank

Statistics

#341

World Rank

#406

Historical Rank

#114

USA Rank

mathematics Degrees

Download Badge

Mathematics

Why Is Daniel J. Schaid Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Daniel J. Schaid's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tamoxifen for early breast cancer: an overview of the randomised trials (1998) (3764)
Microsatellite instability in cancer of the proximal colon. (1993) (3190)
Score tests for association between traits and haplotypes when linkage phase is ambiguous. (2002) (1850)
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. (1999) (1141)
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. (2016) (1110)
Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. (1995) (806)
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. (2001) (760)
Evidence for a prostate cancer susceptibility locus on the X chromosome. (1998) (620)
Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. (1998) (569)
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array (2012) (550)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2018) (509)
Estimation and Tests of Haplotype-Environment Interaction when Linkage Phase Is Ambiguous (2003) (461)
From genome-wide associations to candidate causal variants by statistical fine-mapping (2018) (453)
Anxiety disorders and depressive disorders preceding Parkinson's disease: A case‐control study (2000) (438)
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study (2009) (428)
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer (2014) (416)
The complex genetic epidemiology of prostate cancer. (2004) (400)
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. (1999) (382)
Major Histocompatibility Complex Class I–Recognizing Receptors Are Disease Risk Genes in Rheumatoid Arthritis (2001) (367)
The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. (2001) (357)
Risk tables for parkinsonism and Parkinson's disease. (2002) (348)
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer (2008) (337)
General score tests for associations of genetic markers with disease using cases and their parents (1996) (335)
Evaluating associations of haplotypes with traits (2004) (327)
Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. (2000) (324)
Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. (1997) (314)
Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. (1990) (308)
Genotype relative risks: methods for design and analysis of candidate-gene association studies. (1993) (305)
Incidence of reading disability in a population-based birth cohort, 1976-1982, Rochester, Minn. (2001) (300)
Mutations in CHEK2 associated with prostate cancer risk. (2003) (299)
BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. (2003) (295)
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study (2011) (295)
Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. (1999) (294)
Apolipoprotein E: risk factor for Alzheimer disease. (1994) (283)
Mathematical and Statistical Methods for Genetic Analysis (1999) (265)
Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. (2001) (253)
EFFICACY OF BILATERAL PROPHYLACTIC MASTECTOMY IN WOMEN WITH A FAMILY HISTORY OF BREAST CANCER (1999) (252)
Evidence for a prostate cancer-susceptibility locus on chromosome 20. (2000) (249)
Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. (1997) (235)
Evidence for autosomal dominant inheritance of prostate cancer. (1998) (233)
Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. (1998) (232)
Familial aneurysmal subarachnoid hemorrhage: a community-based study. (1995) (228)
Body-composition changes in patients who gain weight while receiving megestrol acetate. (1993) (228)
Comparison of statistics for candidate-gene association studies using cases and parents. (1994) (221)
A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia (1990) (221)
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. (2005) (220)
Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. (1993) (208)
Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case‐control study (2001) (207)
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors. (2010) (199)
Microsatellite instability in Muir-Torre syndrome. (1994) (191)
Human aromatase: gene resequencing and functional genomics. (2005) (191)
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG) (2012) (186)
Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. (1996) (186)
Smoking, alcohol, and coffee consumption preceding Parkinson’s disease (2000) (181)
Survival study of Parkinson disease in Olmsted County, Minnesota. (2003) (177)
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS (2016) (174)
Factor VIII gene inversions causing severe hemophilia A originate almost exclusively in male germ cells. (1994) (174)
Multiple Novel Prostate Cancer Predisposition Loci Confirmed by an International Study: The PRACTICAL Consortium (2008) (169)
Fine Mapping Causal Variants with an Approximate Bayesian Method Using Marginal Test Statistics (2015) (169)
Case-Control Studies of Genetic Markers: Power and Sample Size Approximations for Armitage’s Test for Trend (2001) (169)
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (163)
A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. (2005) (161)
Sequence analysis of the fragile X trinucleotide repeat: implications for the origin of the fragile X mutation. (1994) (158)
Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer-susceptibility Loci. (2004) (149)
Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. (1991) (147)
Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression. (2008) (147)
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. (2016) (146)
Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis (1994) (143)
Glycine and a Glycine Dehydrogenase (GLDC) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics‐Informed Pharmacogenomics (2011) (143)
Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. (1996) (138)
Reduced COX-2 protein in colorectal cancer with defective mismatch repair. (1998) (138)
Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates: Effect on Low-Density Lipoprotein Cholesterol Levels (the MI-GENES Clinical Trial). (2016) (138)
Expression of p53 and 17p allelic loss in colorectal carcinoma. (1992) (137)
On the Inheritance of Intracranial Aneurysms (1994) (136)
Nonparametric tests of association of multiple genes with human disease. (2005) (135)
Genetic heterogeneity in Peutz‐Jeghers syndrome (2000) (134)
SLC6A4 variation and citalopram response (2009) (134)
The kinship2 R Package for Pedigree Data (2014) (133)
Fluorescence in situ hybridization: a sensitive method for trisomy 8 detection in bone marrow specimens. (1992) (132)
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. (2013) (131)
Major histocompatibility complex class II alleles and the course and outcome of MS (1998) (127)
Choosing a pediatric recipient for orthotopic liver transplantation. (1987) (126)
Transmission disequilibrium, family controls, and great expectations. (1998) (126)
Evaluation of candidate genes in case-control studies: a statistical method to account for related subjects. (2001) (124)
Cervical nodal metastasis of squamous cell carcinoma of unknown origin: indications for withholding radiation therapy. (1992) (123)
Use of parents, sibs, and unrelated controls for detection of associations between genetic markers and disease. (1998) (123)
Evaluation of Genetic Variations in the Androgen and Estrogen Metabolic Pathways as Risk Factors for Sporadic and Familial Prostate Cancer (2007) (120)
Optimal two-stage screening designs for survival comparisons (1990) (117)
Analysis of the RNASEL gene in familial and sporadic prostate cancer. (2002) (117)
Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. (2007) (115)
Where are the prostate cancer genes?—A summary of eight genome wide searches (2003) (115)
A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. (2015) (113)
Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis (1991) (108)
Familial aggregation of Parkinson's disease: The Mayo Clinic family study (2004) (108)
Human SULT1A1 gene: copy number differences and functional implications. (2007) (107)
Identification of an association between HLA class II alleles and low antibody levels after measles immunization. (2001) (103)
Caution on pedigree haplotype inference with software that assumes linkage equilibrium. (2002) (102)
Likelihoods and TDT for the case‐parents design (1999) (101)
Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node‐positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors (1993) (101)
Case‐parents design for gene‐environment interaction (1999) (100)
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression (2013) (100)
Complete responses and long‐term survivals after systemic chemotherapy for patients with advanced malignant melanoma (1989) (98)
Role of HPC2/ELAC2 in hereditary prostate cancer. (2001) (97)
Alpha-1-antitrypsin phenotypes among patients with intracranial aneurysms. (1996) (96)
Human Arsenic Methyltransferase (AS3MT) Pharmacogenetics (2006) (95)
Genomic Similarity and Kernel Methods I: Advancements by Building on Mathematical and Statistical Foundations (2010) (95)
Confirmation of a Positive Association between Prostate Cancer Risk and a Locus at Chromosome 8q24 (2007) (94)
Base of tongue carcinoma: Patterns of failure and predictors of recurrence after surgery alone (1993) (92)
The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis (2005) (92)
Potential influence of migration bias in birth cohort studies. (1998) (92)
Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy (2011) (92)
Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer. (2000) (92)
Validation of a telephone questionnaire for Parkinson's disease. (1998) (92)
TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors. (2002) (90)
Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: Associations with family history and histopathology (2000) (88)
Evidence for a Prostate Cancer Susceptibility Locus on the X Chromosome (1999) (88)
Androgen Stimulation and Laryngeal Development (1985) (86)
Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers (2003) (85)
GLUTATHIONE S-TRANSFERASE OMEGA 1 AND OMEGA 2 PHARMACOGENOMICS (2006) (84)
The gene for HMSN2C maps to 12q23-24 (2003) (83)
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants (2018) (83)
Glutathione s-transferase p1: gene sequence variation and functional genomic studies. (2008) (82)
Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. (2007) (82)
Multiple Genetic Variant Association Testing by Collapsing and Kernel Methods With Pedigree or Population Structured Data (2013) (81)
Germ-line origins of mutation in families with hemophilia B: the sex ratio varies with the type of mutation. (1993) (79)
Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q. (2003) (78)
Genomic Similarity and Kernel Methods II: Methods for Genomic Information (2010) (77)
Reoperations after prophylactic mastectomy with or without implant reconstruction (2003) (77)
Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis (1997) (76)
Linkage Disequilibrium Testing When Linkage Phase Is Unknown (2004) (75)
Glutathione S-Transferase T1 and M1: Gene Sequence Variation and Functional Genomics (2007) (75)
Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics (2006) (75)
Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk. (2020) (74)
Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer. (2010) (73)
Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis. (2006) (72)
Expression of somatostatin receptors in childhood neuroblastoma. (1994) (72)
Effect of megestrol acetate on the human pituitary-adrenal axis. (1992) (71)
BRCA1 and BRCA2 have a limited role in familial prostate cancer. (2000) (71)
Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans (2015) (71)
Cisplatin‐based chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neck (1988) (71)
No association of germline alteration of MSR1 with prostate cancer risk (2003) (70)
Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics (2012) (68)
Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations. (2014) (68)
Prospective validation of HLA-DRB1*07:01 allele carriage as a predictive risk factor for lapatinib-induced liver injury. (2014) (66)
Exact tests of Hardy-Weinberg equilibrium and homogeneity of disequilibrium across strata. (2006) (66)
Increased risk of essential tremor in first‐degree relatives of patients with Parkinson's disease (2007) (66)
The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug. (1987) (65)
Relative efficiency of ambiguous vs. directly measured haplotype frequencies (2002) (65)
Autosomal dominant supravalvular aortic stenosis: localization to chromosome 7. (1993) (63)
Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention. (2013) (63)
Predictive Utility of Polygenic Risk Scores for Coronary Heart Disease in Three Major Racial and Ethnic Groups. (2020) (62)
Methods to impute missing genotypes for population data (2007) (62)
Next generation analytic tools for large scale genetic epidemiology studies of complex diseases (2012) (61)
Progression of familial and non-familial dilated cardiomyopathy: long term follow up (2003) (61)
Human betaine-homocysteine methyltransferase (BHMT) and BHMT2: common gene sequence variation and functional characterization. (2008) (61)
System issues: Spontaneous mutation in Big Blue® transgenic mice: Analysis of age, gender, and tissue type (1996) (61)
Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set (2015) (61)
Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression (2012) (60)
A randomized prospective assessment of recombinant leukocyte A human interferon with or without aspirin in advanced renal adenocarcinoma. (1991) (60)
p53 gene mutations in breast cancers in midwestern US women: null as well as missense-type mutations are associated with poor prognosis. (1994) (60)
Polymorphisms in Mitochondrial Genes and Prostate Cancer Risk (2008) (59)
Current status of adjuvant chemotherapy for colorectal cancer: Can molecular markers play a role in predicting prognosis? (1992) (58)
Validity of family history data on PD (2003) (58)
Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network. (2019) (58)
Genome linkage screen for prostate cancer susceptibility loci: Results from the Mayo Clinic familial prostate cancer study (2003) (56)
Frequency of familial dilated cardiomyopathy. (1995) (56)
Prediction of individual genetic risk to prostate cancer using a polygenic score (2015) (56)
Genetic diversity and function in the human cytosolic sulfotransferases (2007) (56)
Prophylactic mastectomy for BRCA1/2 carriers: progress and more questions. (2004) (55)
Evaluation of CYP2D6 and Efficacy of Tamoxifen and Raloxifene in Women Treated for Breast Cancer Chemoprevention: Results from the NSABP P1 and P2 Clinical Trials (2011) (55)
Potential misinterpretation of the case-only study to assess gene-environment interaction. (1999) (55)
Heritability of plasma amyloid β in typical late‐onset Alzheimer’s disease pedigrees (2001) (54)
Current status of adjuvant chemotherapy for colorectal cancer. Can molecular markers play a role in predicting prognosis? (1992) (54)
ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers (2004) (54)
Sex Differences in Older Adults' Immune Responses to Seasonal Influenza Vaccination (2019) (53)
Prostate cancer and genetic susceptibility: A genome scan incorporating disease aggressiveness (2006) (53)
Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics (2006) (53)
Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation (2016) (52)
Polygenic risk scores in familial Alzheimer disease (2017) (52)
Merging pharmacometabolomics with pharmacogenomics using ‘1000 Genomes’ single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics (2012) (51)
The association of class I HLA alleles and antibody levels after a single dose of measles vaccine. (2003) (51)
Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: comparison of clinical manifestations, chemotherapeutic responses, and prognosis. (1992) (49)
Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. (1994) (49)
Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine (2017) (49)
Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzhei (2014) (48)
Role of the Nijmegen Breakage Syndrome 1 Gene in Familial and Sporadic Prostate Cancer (2006) (48)
Statistical Methods for Testing Genetic Pleiotropy (2016) (48)
Sib‐pair linkage tests for disease susceptibility loci: Common tests vs. the asymptotically most powerful test (1990) (46)
Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases (2015) (46)
Tumor necrosis factor-α allelic frequency and chromosome 6 allelic imbalance in patients with colorectal cancer (1996) (46)
Glutathione Pathway Genetic Polymorphisms and Lung Cancer Survival After Platinum-Based Chemotherapy (2010) (46)
The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease. (2016) (46)
Levamisole potentiation of fluorouracil antiproliferative activity mimicked by orthovanadate, an inhibitor of tyrosine phosphatase. (1992) (46)
Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study (2006) (46)
Case‐control study of debrisoquine 4‐hydroxylase, n‐acetyltransferase 2, and apolipoprotein e gene polymorphisms in Parkinson's disease (2000) (46)
Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer. (2001) (45)
Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk EstimatesCLINICAL PERSPECTIVE (2016) (45)
Mapping Complex Traits in a Diversity Outbred F1 Mouse Population Identifies Germline Modifiers of Metastasis in Human Prostate Cancer. (2017) (44)
Regression Models for Linkage: Issues of Traits, Covariates, Heterogeneity, and Interaction (2003) (44)
TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression. (2013) (44)
Identification of Novel Variants in Colorectal Cancer Families by High-Throughput Exome Sequencing (2013) (42)
Fast and robust adjustment of cell mixtures in epigenome-wide association studies with SmartSVA (2017) (42)
The influence of the HLA-DRB1*13 allele on measles vaccine response. (1996) (42)
The association between HLA class I alleles and measles vaccine-induced antibody response: evidence of a significant association. (1998) (42)
DNA ploidy and the percentage of cells in S‐phase as prognostic factors for women with lymph node negative breast cancer (1994) (42)
Barrett's esophagus: prevalence in symptomatic relatives. (2002) (41)
Using the gene ontology to scan multilevel gene sets for associations in genome wide association studies (2012) (41)
Small Sample Kernel Association Tests for Human Genetic and Microbiome Association Studies (2016) (41)
Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics. (2014) (41)
Incorporating Functional Annotations for Fine-Mapping Causal Variants in a Bayesian Framework Using Summary Statistics (2016) (40)
Association of Peutz‐Jeghers‐like Mucocutaneous Pigmentation with Breast and Gynecologic Carcinomas in Women (2000) (40)
Polymorphisms of the TAP2 gene may influence antibody response to live measles vaccine virus. (1997) (40)
A Novel Mutation in KVLQT1 Is the Molecular Basis of Inherited Long QT Syndrome in a Near-Drowning Patient's Family (1998) (40)
Disseminated malignant melanoma and recombinant interferon: analysis of seven consecutive phase II investigations. (1990) (39)
Treatment Outcomes of Depression: The Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study (2014) (39)
Tonsil cancer. Patterns of failure after surgery alone and surgery combined with postoperative radiation therapy (1994) (39)
DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials. (1993) (39)
Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease. (2007) (38)
Inflammatory Breast Cancer: Integration of Irradiation, Surgery, and Chemotherapy (1992) (38)
Fine-Mapping the HOXB Region Detects Common Variants Tagging a Rare Coding Allele: Evidence for Synthetic Association in Prostate Cancer (2014) (38)
Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination. (1998) (38)
Genetic and physical mapping of a novel region close to the fragile X site on the human X chromosome. (1989) (37)
Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2018) (37)
Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccine. (2002) (37)
Human glucocorticoid receptor alpha gene (NR3C1) pharmacogenomics: gene resequencing and functional genomics. (2009) (37)
Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. (2008) (37)
Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. (2007) (37)
Power comparisons between similarity‐based multilocus association methods, logistic regression, and score tests for haplotypes (2009) (37)
Power and Sample Size for Testing Associations of Haplotypes with Complex Traits (2006) (37)
Familial occurrence of carcinoid tumors and association with other malignant neoplasms. (1999) (36)
A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches (2007) (36)
Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue double transgenic mice. (1996) (36)
An evaluation of recombinant leukocyte a interferon with aspirin in patients with metastatic renal cell cancer (1988) (36)
Kernel methods for large-scale genomic data analysis (2015) (35)
Description of the international consortium for prostate cancer genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13 (2005) (35)
Barrett's esophagus: prevalence in symptomatic relatives (2002) (34)
Allelic Imbalance and Microsatellite Instability in Resected Duke's D Colorectal Cancer (1997) (34)
Phase II Trial of Recombinant Tumor Necrosis Factor in Disseminated Malignant Melanoma (1992) (34)
Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study (2012) (34)
Genotype relative‐risks and association tests for nuclear families with missing parental data (1997) (34)
Current perspectives in assessing humoral immunity after measles vaccination (2019) (33)
Comprehensively evaluating cis-regulatory variation in the human prostate transcriptome by using gene-level allele-specific expression. (2015) (33)
A double‐blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the north central cancer treatment group and mayo clinic (1991) (33)
Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics (2006) (32)
Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21 (2016) (32)
A design for phase II testing of anticancer agents within a phase III clinical trial. (1988) (31)
Erratum: Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value (Proceedings of the National Academy of Science of the USA (February 6, 1996) 93 (1093-1096)) (1996) (30)
The Mayo Clinic Family Study of Parkinson’s Disease: Study Design, Instruments, and Sample Characteristics (2005) (30)
Genome-Wide Association Study of Prostate Cancer–Specific Survival (2015) (30)
Mutational specificity: Mutation frequencies but not mutant frequencies in Big Blue® mice fit a Poisson distribution (1996) (30)
A Prospective, Randomized Controlled Trial of Megestrol Acetate Among High‐Risk Patients with Resected Malignant Melanoma (1989) (29)
Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer (2012) (29)
Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage. (2009) (29)
Sequential haplotype scan methods for association analysis (2007) (29)
ORIENTATION OF LOCI IN THE MAJOR HISTOCOMPATIBILITY COMPLEX OF THE RAT AND ITS COMPARISON TO MAN AND THE MOUSE (1982) (29)
Regression models for linkage heterogeneity applied to familial prostate cancer. (2001) (28)
Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease (2014) (27)
The genomic organization of human dystrobrevin (1997) (27)
Human Hydroxysteroid Sulfotransferase SULT2B1 Pharmacogenomics: Gene Sequence Variation and Functional Genomics (2007) (27)
Lessons learned in the analysis of high-dimensional data in vaccinomics. (2015) (27)
A Kernel Regression Approach to Gene‐Gene Interaction Detection for Case‐Control Studies (2013) (26)
The location of the Philadelphia chromosomal breakpoint site and prognosis in chronic granulocytic leukemia. (1990) (26)
Phase II study of ifosfamide-etoposide-mesna in adults with advanced nonosseous sarcomas. (1989) (26)
Genetic epidemiology and haplotypes (2004) (26)
Early-stage squamous cell carcinoma of the glottic larynx managed with radiation therapy. (1992) (26)
Molecular epidemiology of breast cancers in northern and southern Japan: the frequency, clustering, and patterns of p53 gene mutations differ among these two low-risk populations. (1996) (26)
A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data (2019) (26)
Genome‐wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for prostate cancer Genetics using novel sumLINK and sumLOD analyses (2010) (26)
Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines (2014) (26)
Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer. (1988) (26)
A small‐sample kernel association test for correlated data with application to microbiome association studies (2018) (25)
Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer. (2020) (25)
Novel pattern of P53 mutation in breast cancers from Austrian women. (1995) (25)
Genome-wide linkage scan of prostate cancer Gleason score and confirmation of chromosome 19q (2007) (24)
Discovery of cancer susceptibility genes: study designs, analytic approaches, and trends in technology. (1999) (24)
Evaluation of the continuous infusion of etoposide plus cisplatin in metastatic breast cancer a collaborative north central cancer treatment group/mayo clinic phase ii study (1990) (24)
Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG) (2012) (23)
Score tests for association of traits with haplotypes when linkage phase is ambiguous (2002) (23)
Clinical options for women at high risk for breast cancer. (1999) (22)
Gluthatione-S-transferase P1 polymorphism I105V in familial and sporadic prostate cancer. (2004) (22)
Genetically defined race, but not sex, is associated with higher humoral and cellular immune responses to measles vaccination. (2016) (22)
Recombinant Interferons in the Management of Advanced Malignant Melanoma Updated Review of Five Prospective Clinical Trials and Long‐Term Responders (1988) (21)
Family-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk locus. (2010) (21)
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2 (2015) (21)
A phase I‐II trial of the combination of recombinant leukocyte a interferon and recombinant human interferon‐γ in patients with metastatic malignant melanoma (1988) (21)
Inbreeding among Caribbean Hispanics from the Dominican Republic and the Effects on the Risk of Alzheimer's Disease (2014) (21)
Case-only exome sequencing and complex disease susceptibility gene discovery: study design considerations (2014) (21)
An intronic region within the human factor VIII gene is duplicated within Xq28 and is homologous to the polymorphic locus DXS115 (767). (1989) (21)
Candidate‐gene association studies with pedigree data: Controlling for environmental covariates (2003) (21)
Prevalence and clinical significance of HFE gene mutations in patients with iron overload. (2000) (20)
Case‐control study of estrogen receptor gene polymorphisms in Parkinson's disease (2002) (20)
A Phase II Study of 5,6‐Dihydro‐5‐Azacytidine Hydrochloride in Disseminated Malignant Melanoma (1993) (20)
Quantitative trait transmission disequilibrium test: Allowance for missing parents (1999) (20)
A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses (2017) (19)
Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study (2021) (19)
Relative‐risk regression models using cases and their parents (1995) (19)
A phenome-wide association study to discover pleiotropic effects of PCSK9, APOB, and LDLR (2019) (19)
5‐Fluorouracil Plus Leucovorin in Women with Metastatic Breast Cancer A Phase II Study (1991) (19)
Mutational landscape of candidate genes in familial prostate cancer (2014) (18)
Randomized Trial of Doxorubicin Alone or Combined with Vincristine and Mitomycin C in Women with Metastatic Breast Cancer (1989) (18)
Erratum: Glutathione S-transferase omega 1 and omega 2 pharmacogenomics (Drug Metabolism and Disposition (2006) 34 (1237-1246)) (2006) (18)
Atlas-CNV: a validated approach to call single-exon CNVs in the eMERGESeq gene panel (2018) (18)
Robust multipoint identical-by-descent mapping for affected relative pairs. (2005) (17)
Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies (1993) (17)
Genome analysis and pleiotropy assessment using causal networks with loss of function mutation and metabolomics (2019) (17)
Frequency of Defective DNA Mismatch Repair in Colorectal Cancer among the Alaska Native People (2007) (17)
Detection of preclinical Parkinson disease in at-risk family members with use of [123I]beta-CIT and SPECT: an exploratory study. (1999) (17)
Genic interaction causing embryonic mortality in the rat: epistasis between the Tal and grc genes. (1982) (16)
A review of kernel methods for genetic association studies (2019) (16)
Does histologic grade in soft tissue sarcoma influence response rate to systemic chemotherapy? (1991) (16)
Familial medullary thyroid cancer and prominent corneal nerves: clinical and genetic analysis. (1995) (15)
Correlations between measles, mumps, and rubella serum antibody levels in Olmsted County school children. (2001) (15)
A Comprehensive Examination of CYP19 Variation and Breast Density (2007) (15)
Genome-wide polygenic score to predict chronic kidney disease across ancestries (2022) (15)
Hereditary motor and sensory neuropathy type 2C is genetically distinct from types 2B and 2D. (2000) (15)
Anticipation in familial Parkinson's disease (1996) (15)
Detecting genomic clustering of risk variants from sequence data: cases versus controls (2013) (15)
Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG (2012) (14)
Estimation of genotype relative risks from pedigree data by retrospective likelihoods (2010) (14)
Linkage of nonspecific X-linked mental retardation to Xq21.31. (1992) (14)
Human SULT 1 A 1 gene : copy number differences and functional implications (2007) (14)
Tumor necrosis factor-alpha allelic frequency and chromosome 6 allelic imbalance in patients with colorectal cancer. (1996) (14)
Trees Assembling Mann‐Whitney Approach for Detecting Genome‐Wide Joint Association Among Low‐Marginal‐Effect Loci (2013) (14)
The prognosis of familial versus nonfamilial aneurysmal subarachnoid hemorrhage. (1996) (13)
Methylenetetrahydrofolate Reductase Haplotype Tag Single-Nucleotide Polymorphisms and Risk of Breast Cancer (2006) (13)
Multivariate generalized linear model for genetic pleiotropy (2017) (13)
Radiation therapy for squamous cell carcinoma of the tonsil. (1994) (13)
Human phenylethanolamine N-methyltransferase genetic polymorphisms and exercise-induced epinephrine release. (2008) (13)
Catechol O-methyltransferase pharmacogenomics: human liver genotype–phenotype correlation and proximal promoter studies (2009) (13)
Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes (2017) (12)
Two‐Phase Designs to Follow‐Up Genome‐Wide Association Signals With DNA Resequencing Studies (2013) (12)
Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus–Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination (2018) (12)
Confirmation of linkage of supravalvular aortic stenosis to the elastin gene on chromosome 7q. (1994) (12)
Germline origins in the human F9 gene: frequent G:C→A:T mosaicism and increased mutations with advanced maternal age (1999) (12)
Power of Single‐ vs. Multi‐Marker Tests of Association (2012) (12)
Detecting potential pleiotropy across cardiovascular and neurological diseases using univariate, bivariate, and multivariate methods on 43,870 individuals from the eMERGE network (2018) (12)
No fumarate hydratase (FH) mutations in hereditary prostate cancer (2003) (12)
The effect of sample size on polygenic hazard models for prostate cancer (2019) (12)
Model‐free sib‐pair linkage analysis: Combining full‐sib and half‐sib pairs (2000) (11)
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2019) (11)
Tumor-ablative surgery, microvascular free tissue transfer reconstruction, and postoperative radiation therapy for advanced head and neck cancer. (1994) (11)
Robust transmission regression models for linkage and association (2000) (11)
Genetic heterogeneity in hereditary sensory and autonomic neuropathies: The need for improved ascertainment (2000) (11)
A Weighted U‐Statistic for Genetic Association Analyses of Sequencing Data (2014) (11)
Genetic variants associated with susceptibility to psychosis in late-onset Alzheimer’s disease families (2015) (11)
Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genes (2016) (11)
Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk. (2006) (10)
Heritability of vaccine-induced measles neutralizing antibody titers. (2017) (10)
Oral haloperidol lowers human intraocular pressure. (1986) (10)
Penalized models for analysis of multiple mediators (2020) (10)
Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb (2008) (10)
Regularized Rare Variant Enrichment Analysis for Case‐Control Exome Sequencing Data (2014) (10)
A Randomized Trial of Cyclophosphamide, Doxorubicin, and Prednisone Versus Cyclophosphamide, 5‐Fluorouracil, and Prednisone in Patients with Metastatic Breast Cancer (1991) (9)
gsSKAT: Rapid gene set analysis and multiple testing correction for rare‐variant association studies using weighted linear kernels (2017) (9)
Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array (2016) (9)
Prevalence and clinical significance of HFE gene mutations in patients with iron overload (2000) (9)
The impact of HLA-DRB 1 genes on extra-articular disease manifestations in rheumatoid arthritis (2005) (9)
Selective Estrogen Receptor Modulators and Pharmacogenomic Variation in ZNF 423 Regulation of BRCA 1 Expression : Individualized Breast Cancer Prevention (2013) (9)
Phase II trial of recombinant leukocyte A interferon (IFN-alpha 2A) plus 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and the combination cimetidine with BCNU in patients with disseminated malignant melanoma. (1991) (8)
Role of HPC 2 / ELAC 2 in Hereditary Prostate Cancer 1 (2001) (8)
Corrigendum to Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression [Human Molecular Genetics, 22, (2013), 2520-2528] doi: 10.1093/hmg/ddt086 (2013) (8)
A multi-locus genetic risk score for abdominal aortic aneurysm. (2016) (8)
Expression of a potential metastasis suppressor gene (nm23) in thyroid neoplasms (1993) (8)
Exclusion of a primary gene defect at the HLA locus in familial idiopathic dilated cardiomyopathy. (1995) (8)
Genetic Predictors of Chemotherapy-Induced Peripheral Neuropathy from Paclitaxel, Carboplatin and Oxaliplatin: NCCTG/Alliance N08C1, N08CA and N08CB Study (2021) (8)
Evaluation of Trilostane Plus Hydrocortisone in Women with Metastatic Breast Cancer and Prior Hormonal Therapy Exposure (1990) (8)
Phase II Assessment of Recombinant Leukocyte A Interferon with Difluoromethylornithine in Disseminated Malignant Melanoma (1990) (8)
Genotype determination for polymorphisms in linkage disequilibrium (2009) (8)
A Bayesian hierarchical nonlinear model for assessing the association between genetic variation and drug cytotoxicity (2009) (8)
Genetic predictors of chemotherapy-related amenorrhea in women with breast cancer. (2019) (8)
GENEHUNTER: Application to analysis of bipolar pedigrees and some extensions (1997) (8)
Barrett's esophagus: Prevalence in relatives with and without frequent symptoms (2001) (7)
Disease-Marker Association (2005) (7)
Polymorphisms in STING Affect Human Innate Immune Responses to Poxviruses (2020) (7)
Phase II Evaluation of Menogaril in Women with Metastatic Breast Cancer after Failure of First‐Line Chemotherapy (1988) (7)
Genome-wide linkage analyses of hereditary prostate cancer families with colon cancer provide further evidence for a susceptibility locus on 15q11–q14 (2010) (7)
Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families (2012) (7)
Regression Modeling of Allele Frequencies and Testing Hardy Weinberg Equilibrium (2013) (7)
Post hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case‐Control Sequencing Studies (2016) (6)
Targeted Sequencing Study to Uncover Shared Genetic Susceptibility Between Peripheral Artery Disease and Coronary Heart Disease-Brief Report. (2019) (6)
The Mayo Clinic studies (1993) (6)
A phase I-II trial of the combination of recombinant leukocyte A interferon and recombinant human interferon-gamma in patients with metastatic malignant melanoma. (1988) (6)
An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set (2019) (6)
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer (1989) (6)
Testing Genetic Linkage with Relative Pairs and Covariates by Quasi-Likelihood Score Statistics (2007) (6)
Barrett's esophagus: A familial disorder? (2000) (6)
PedBLIMP: Extending Linear Predictors to Impute Genotypes in Pedigrees (2014) (6)
Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants. (2014) (6)
Two-stage case–control designs for rare genetic variants (2010) (6)
Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine (2017) (5)
Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents. (2021) (5)
Phase II study of the combination of vinblastine plus cisplatin administered by continuous 120-hour infusion for patients with advanced malignant melanoma. (1987) (5)
Minority-centric meta-analyses of blood lipid levels identify novel loci in the Population Architecture using Genomics and Epidemiology (PAGE) study (2020) (5)
Anti-mullerian hormone as a serum biomarker for risk of chemotherapy-induced amenorrhea. (2020) (5)
Robust Multipoint Simultaneous Identical-by-Descent Mapping for Two Linked Loci (2007) (5)
“Reply to Fallin et al.” (2002) (4)
Reply to “a powerful test of sib‐pair linkage for disease susceptibility” (1991) (4)
Genetic epidemiology and microarrays (2002) (4)
Postoperative irradiation for tonsillar carcinoma. (1993) (4)
A DAB2IP genotype: sex interaction is associated with abdominal aortic aneurysm expansion (2017) (4)
Impact of a breast cancer (BC) polygenic risk score (PRS) on the decision to take preventive endocrine therapy (ET): The Genetic Risk Estimate (GENRE) trial. (2019) (4)
Associations between measles antibody levels and the protein structure of class II human leukocyte antigens. (2003) (4)
Evaluation of Menogaril in Patients with Metastatic Sarcomas and No Prior Chemotherapy Exposure (1989) (4)
Identification of putative nonfunctional steroid receptors in breast and endometrial cancer. (1990) (4)
Carrier identification of cystic fibrosis by recombinant DNA techniques. (1989) (4)
Affected relative pairs and simultaneous search for two‐locus linkage in the presence of epistasis (2007) (3)
Phase II Trial of VP‐16, Bleomycin, and Cisplatin in Patients with Advanced Nonsquamous Cell Head and Neck Neoplasms (1993) (3)
Penalized variance components for association of multiple genes with traits (2020) (3)
Re: probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. (1997) (3)
Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2019) (3)
Identifying single-nucleotide polymorphisms responsible for the linkage signal of rheumatoid arthritis on chromosome 6 by joint modeling of linkage and association (2007) (3)
Systemic adjuvant therapy in women with resected node-negative breast cancer. (1991) (3)
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (3)
Combining two‐point genetic linkage analyses using mapping functions (1994) (3)
Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake (2020) (3)
Abstract PD05-02: Genome-Wide Associations of Breast Events and Functional Genomic Studies in High-Risk Women Receiving Tamoxifen or Raloxifene on NSABP P1 and P2 Prevention Trials. A Pharmacogenomics Research Network-RIKEN-NSABP Collaboration (2010) (3)
Progress report on a phase II trial of 5-fluorouracil plus citrovorum factor in women with metastatic breast cancer. (1988) (3)
Need to confirm promising case‐control association studies: Reply to Sham (1994) (3)
Comment [3] (multiple letters) (2002) (2)
Genetic Variations and Health-Related Quality of Life (HRQOL): A Genome-Wide Study Approach (2021) (2)
Transcriptional signatures associated with rubella virus‐specific humoral immunity after a third dose of MMR vaccine in women of childbearing age (2021) (2)
Network-directed cis-mediator analysis of normal prostate tissue expression profiles reveals downstream regulatory associations of prostate cancer susceptibility loci (2017) (2)
Genetic variants associated with susceptibility to psychosis in Late Onset Alzheimer Disease families (2015) (2)
A microRNA Transcriptome-wide Association Study of Prostate Cancer Risk (2022) (2)
Cd4+ cd28- T lymphocytes in rheumatoid arthritis (ra) (1996) (2)
Application of sequential haplotype scan methods to case-control data (2007) (2)
Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lung. (1996) (2)
2dFDR: a new approach to confounder adjustment substantially increases detection power in omics association studies (2021) (2)
A Bivariate Mann‐Whitney Approach for Unraveling Genetic Variants and Interactions Contributing to Comorbidity (2013) (2)
Abstract PD10-05: HLA-DQA1*02:01/DRB1*07:01 as a biomarker for lapatinib-induced hepatotoxicity: prospective confirmation in a large randomised clinical trial (TEACH, EGF105485) (2012) (2)
A Genome-Wide Association Study in Patients Experiencing Musculoskeletal Adverse Events on Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer Entered on NCIC CTG Trial MA.27. A Pharmacogenetics Research Network-RIKEN Collaboration. (2009) (2)
Glutathione S-Transferase T 1 andM 1 : Gene Sequence Variation and Functional Genomics (2007) (2)
One- and two-locus models for mapping rheumatoid arthritis-susceptibility genes on chromosome 6 (2007) (2)
A Powerful Nonparametric Statistical Framework for Family-Based Association Analyses (2015) (2)
Response to Li and Hopper. (2021) (2)
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (2)
Family-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L 3 region on chromosome 22 q 12 as a risk locus (2010) (2)
Age-Specific Incidence Rate For Dementia And Alzheimer’s Disease In NIA-LOAD/NCRAD and EFIGA Families (P2.148) (2014) (2)
Immunoglobulin GM and KM genes and measles vaccine-induced humoral immunity. (2017) (1)
From classical mendelian randomization to causal networks for systematic integration of multi-omics (2022) (1)
Erratum: Pooled genome linkage scan of aggressive prostate cancer: Results from the International Consortium for Prostate Cancer Genetics (Human Genetics (2007) vol. 120 (4) 10.1007/s00439-006-0219-9) (2007) (1)
Aromatase inhibitors , estrogens and musculoskeletal pain : estrogen-dependent T-cell leukemia 1 A ( TCL 1 A (2012) (1)
Large-scale genomic analyses reveal insights into pleiotropy across circulatory system diseases and nervous system disorders (2022) (1)
Testing whether genetic variation explains correlation of quantitative measures of gene expression, and application to genetic network analysis (2008) (1)
Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression (2012) (1)
Lack of referral bias in genetic studies of prostate cancer. (2002) (1)
Advances in Brief TBX 2 Is Preferentially Amplified in BRCA 1-and BRCA 2-related Breast Tumors 1 (2002) (1)
Returning integrated genomic risk and clinical recommendations: the eMERGE study. (2023) (1)
Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG) (2011) (1)
Genome-wide polygenic score with APOL1 risk genotypes predicts chronic kidney disease across major continental ancestries (2021) (1)
Phase II study of carmustine in advanced upper aerodigestive cancer. (1987) (1)
Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study (2012) (1)
A rare variant analysis framework using public genotype summary counts to prioritize disease-predisposition genes (2022) (1)
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants (2018) (1)
Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Breast Cancer Patients. (2022) (1)
Abstract 2271: Metformin pharmacogenomics: A genome-wide associate study to identify genetic and epigenetic biomarkers involved in metformin response. (2013) (1)
Is TAP gene polymorphism important in measles vaccine response (1994) (1)
Acquired Chromosomal Anomalies in Chronic Lymphocytic Leukemia (CLL) Patients Compared to >50,000 Quasi-normal Subjects (2014) (1)
Familial recurrence risk with varying amount of family history (2019) (1)
2dFDR: a new approach to confounder adjustment substantially increases detection power in omics association studies (2021) (1)
Genome-Wide Determinants of Cellular Immune Responses to Mumps Vaccine (2023) (0)
Polymorphisms of the promoter region of the tumor necrosis factor α gene and the outcome of MS (1995) (0)
Phase II Trial of Recombinant Leukocyte A Interferon (IFN‐α2A) Plus l,3‐Bis(2‐Chloroethyl)‐1‐Nitrosourea (BCNU) and the Combination Cimetidine with BCNU in Patients with Disseminated Malignant Melanoma (1991) (0)
Abstract 2742: Assessment of next generation platforms and use of duplicate runs for whole exome sequencing (2011) (0)
Genome analysis and pleiotropy assessment using causal networks with loss of function mutation and metabolomics (2019) (0)
Exclusion of calcitonin/alpha-CGRP gene defect in a family with autosomal dominant supravalvular aortic stenosis. (1992) (0)
Pleiotropy tests for quantitive, binary, and ordinal traits with covariates (2017) (0)
Plasma β‐Amyloid as a Surrogate Genetic Marker in Late‐Onset Alzheimer's Disease (2002) (0)
Cervical nodal metastasis of unknown origin: indications for withholding radiotherapy radiotherapy (1991) (0)
From genome-wide associations to candidate causal variants by statistical fine-mapping (2018) (0)
Attention-Deficit/Hyperactivity Disorder(ADHD) Occurrence Among Reading Disabled (RD) and Non-RD Children in a Population-Based Birth Cohort (2000) (0)
Genetic epidemiology (2001) (0)
DNA methylation partially mediates the relationship between childhood adversity and depressive symptoms in adolescence (2021) (0)
Abstract PS8-02: Influence of a breast cancer polygenic risk score on adherence to preventive endocrine therapy in high risk women at 1 and 2 year follow-up: The genetic risk estimate (GENRE) trial (2021) (0)
Microsatellite Instability in Muir-Torre Syndrome1 (2006) (0)
Genome Wide Association Studies of Complex Diseases (2006) (0)
538 Association of class II HLA-DQ alleles and antibody response after mesles immunization: Preliminary results (2000) (0)
The effect of sample size on polygenic hazard models for prostate cancer (2020) (0)
Polygenic risk for prostate cancer: Decreasing relative risk with age but little impact on absolute risk. (2022) (0)
Efficacy o f C ontralateral P rophylactic M astectomy in W omen W ith a P ersonal a nd F amily H istory o f Breast C ancer (2001) (0)
Regularized Mediation Analysis [R package regmed version 1.1.0] (2020) (0)
Comparison of the Effects of Pentaerythritol Tetranitrate and Nitroglycerin on Endothelium- Dependent Vasorelaxation in Male Volunteers (2003) (0)
Practical information on getting the most from Genetic Epidemiology (2003) (0)
Haplotype-tagging analyses of aromatase (CYP19) and risk of breast cancer. (2006) (0)
Searching for epistasis and linkage heterogeneity by correlations of pedigree‐specific linkage scores (2008) (0)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2018) (0)
Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2019) (0)
Fine-mapping identifies multiple prostate cancer risk loci on 5p15 some associating with TERT expression (2013) (0)
Erratum: (Journal of Clinical Investigation (February 1995) 95:2 (688)) (1995) (0)
Author response for "Transcriptional signatures associated with rubella virus‐specific humoral immunity after a third dose of MMR vaccine in women of childbearing age" (2021) (0)
A genetic hazard score to personalize prostate cancer screening, applied to population data (2019) (0)
Whole-Exome Sequence Scan in Pedigrees and Controls: Applications and Co-Segregation Methods (2014) (0)
Abstract PD3-03: Impact of the breast cancer polygenic risk score on preventive endocrine therapy adherence and endocrine therapy usage on quality of life - The Genetic Risk Estimate (GENRE) trial (2020) (0)
Ocular hypotensive effect of haloperidol. (1986) (0)
Null Results in Brief Methylenetetrahydrofolate Reductase Haplotype Tag Single-Nucleotide Polymorphisms and Risk of Breast Cancer (2006) (0)
Abstract 2548: Targeted sequencing to identify rare variants in colorectal cancer. (2013) (0)
SCANNING THE PHENOME TO UNCOVER PLEIOTROPIC EFFECTS OF PCSK9 (2017) (0)
Abstract 14663: High Rate of Arrhythmia Diagnoses Following Return of Pathogenic/likely Pathogenic Variants in an Unselected Population (2020) (0)
Tumor Necrosis Factor-a Allelic Frequency and Chromosome 6 Allelic Imbalance (2006) (0)
Randomized Trials in Cancer: A Critical Review by Sites (Monograph Series of the European Organization for Research on Treatment of Cancer [EORTC], Vol 15) (1987) (0)
Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases (2015) (0)
Contents, Vol. 51, Supplement 1, 1994 (1994) (0)
Disease-Marker Association† (2014) (0)
Abstract 1285: Genetic variations predicting cisplatin cytotoxicity associated with the overall survival in lung cancer patients receiving platinum-based chemotherapy (2011) (0)
Prediction of individual variation in thiopurine response phenotypes from genome‐wide association studies (2008) (0)
Contents Vol. 64, 2007 (2007) (0)
471: Effect of a Family History of Prostate Cancer on Outcome After Radical Retropubic Prostatectomy (2004) (0)
Penalized mediation models for multivariate data (2021) (0)
Breast pathology in women with personal and family history of breast cancer, including BRCA1/2 mutation carriers: A model for cancer progression (2001) (0)
1 Title : Post-hoc Analysis for Detecting Individual Rare Variant Risk Associations using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing Studies Running Title : Bayesian Probit Rare Variant Analysis (2017) (0)
of sample on polygenic hazard models for prostate cancer. (2020) (0)
STATISTICAL GENETICS ’98 Transmission Disequilibrium, Family Controls, and Great Expectations (1998) (0)
P4472Targeted sequencing of 80 pharmacogenes reveals evidence for pleiotropic effects on serum LDL cholesterol levels (2017) (0)
Abstract P6-10-03: The contribution of common genetic variation to breast cancer risk among women receiving tamoxifen or raloxifene within the National Surgical Adjuvant Breast and Bowel Project (NSABP) P-1 and P-2 trials (2015) (0)
Gender and Incidence of Reading Disorder in a Birth Cohort, 1976-1982, (1999) (0)
Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease (2013) (0)
Oral Session I‐A (OI‐A) (2011) (0)
Abstract C114: Androstenedione levels in postmenopausal women with resected early-stage breast cancer are associated with SNPs in CYP11B1 and CYP11B2 identified by a genome-wide association study (GWAS). (2011) (0)
Fast and robust adjustment of cell mixtures in epigenome-wide association studies with SmartSVA (2017) (0)
pedgene package vignette Version 2.0 (2014) (0)
Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2018) (0)
Detecting genomic clustering of risk variants from sequence data: cases versus controls (2013) (0)
Abstract 16182: Jay D. Coffman Early Career Investigator Award: Large-scale Targeted Sequencing of Genomic Regions Associated With Coronary Heart Disease Uncovers Evidence for Polygenic Overlap With Peripheral Arterial Disease (2016) (0)
Title: A powerful non-parametric statistical framework for family-based (2015) (0)
Membrane-Bound (MB) Catechol-O-Methyltransferase (COMT) Genetic Polymorphisms, Catechol Estrogen Conjugation and Breast Cancer Risk Reduction (2008) (0)
GLUTATHIONE S -TRANSFERASE OMEGA 1 AND OMEGA 2 PHARMACOGENOMICS □ S (2006) (0)
Microsatellite Instabifity in Colorectal Cancer : Different Mutator Phenotypes and the Principal Involvement of hMLHJ 1 (2006) (0)
SEX DIFFERENCES IN ABDOMINAL AORTIC ANEURYSM EXPANSION (2016) (0)
Conference Scene: Lessons learned from the 5th Statistical Analysis Workshop of the Pharmacogenetics Research Network. (2010) (0)
Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes (2017) (0)
Use of Polygenic Risk Scores for Coronary Heart Disease in Ancestrally Diverse Populations (2022) (0)
Abstract B40: Rare variant discovery in known cancer genes from whole-exome sequencingof African American hereditary prostate cancer families (2016) (0)
Genome-Wide LinkageAnalysis of 1 , 233 Prostate Cancer Pedigrees Fromthe International Consortium for ProstateCancerGeneticsUsingNovel sumLINKandsumLODAnalyses (2010) (0)
Subspecialty Clinics: Medical Genetics Carrier Identification of Cystic Fibrosis by Recombinant (1989) (0)
Overview of Statistical Genetic Concepts for Pharmacogenomic Studies (2008) (0)
An Intronic RegionwithintheHuman FactorVilGene IsDuplicated within Xq28andIsHomologous tothe Polymorphic LocusDXSI15(767) (1989) (0)
Abstract 4727: Breast cancer prevention and selective estrogen response modulators (SERMs): Pharmacogenomics and differential estrogen and SERM regulation of BRCA1 and BRCA2 expression (2011) (0)
Evidence of epistasis in regions of long-range linkage disequilibrium across five complex diseases in the UK Biobank and eMERGE datasets (2022) (0)
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2019) (0)
Defining genetic predisposition to multifactorial disease: Application of a two-tiered association approach to schizophrenia (1993) (0)
contrast, approximately 15â€”20%of colorectal neoplasms arise through a distinct genetic pathway characterized by microsatellite Instability (MSI) associated with frequent loss of expression of one of the DNA mismatch (2006) (0)
A phenome-wide association study to discover pleiotropic effects of PCSK9, APOB, and LDLR (2019) (0)
104 Lack of referral bias in genetic studies of prostate cancer (2002) (0)
Uterine fibroid polygenic risk score (PRS) associates and predicts risk for uterine fibroid (2022) (0)
Editorial (2001) (0)
Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21 (2016) (0)
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (0)
Genes regulating estradiol and estrone-conjugate levels in postmenopausal women with resected early-stage breast cancer detected by a genome-wide association study (GWAS). (2011) (0)
Abstract 37: A Multi-locus Genetic Risk Score for Abdominal Aortic Aneurysm (2015) (0)
Advances in Brief Microsatellite Instability in Muir-Torre Syndrome 1 (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Daniel J. Schaid?

Daniel J. Schaid is affiliated with the following schools:

Daniel J. Schaid's Academic­Influence.com Rankings

Why Is Daniel J. Schaid Influential?

Daniel J. Schaid's Published Works

Published Works

What Schools Are Affiliated With Daniel J. Schaid?

Daniel J. Schaid's AcademicInfluence.com Rankings